UK appellate court weighs in on Swiss-type claims
The Court of Appeal of England and Wales has provided guidance on the construction of a second medical use patent with Swiss-type claims for the purposes of establishing infringement, and followed Dutch and German case law in finding an arguable case for indirect infringement of such patent
Background to the dispute
In summary, Warner-Lambert had a patent for the drug pregabalin which it marketed under the trade mark Lyrica for epilepsy, generalised anxiety disorder (non-patented indication) and neuropathic pain.
The patent and data exclusivity for the drug...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.